Approval · Notice of Compliance 24527 · 2020
LOSEC: Notice of Compliance 24527
Issued November 2, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24527
- Date
- November 2, 2020
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownerhsp. change in brand name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOSEC | 02190915 | Cancelled Post Market |
Medicinal ingredients
- OMEPRAZOLE MAGNESIUM 22.5 MG per TAB